BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Editorial
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease 
Agustin Castiella, Eva Zapata, M Isabel Lucena, Raúl J Andrade 
World J Hepatol 6(4):160-168. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.160
Review
Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver 
Laura Vergani 
World J Hepatol 6(4):169-177. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.169
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis 
Christos Tsaitas, Anysia Semertzidou, Emmanouil Sinakos 
World J Hepatol 6(4):178-187. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.178
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease 
Sara Heebøll, Karen Louise Thomsen, Steen B Pedersen, Hendrik Vilstrup, Jacob George, Henning Grønbæk 
World J Hepatol 6(4):188-198. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.188
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease 
Zeynel Abidin Ozturk, Abdurrahman Kadayifci 
World J Hepatol 6(4):199-206. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.199
Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition 
Sun-Jae Lee, Kyung-Hyun Kim, Kwan-Kyu Park 
World J Hepatol 6(4):207-216. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.207
Minireviews
Pediatric non-alcoholic fatty liver disease: New insights and future directions 
Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Nicola Santoro 
World J Hepatol 6(4):217-225. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.217
To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy 
Mohamed A Mekky 
World J Hepatol 6(4):226-229. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.226
Original Article
Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions 
Kangsadarn Bennukul, Sucha Numkliang, Vijittra Leardkamolkarn 
World J Hepatol 6(4):230-242. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.230
Brief Article
Murine model to study brain, behavior and immunity during hepatic encephalopathy 
Lindisley Ferreira Gomides, Pedro Elias Marques, Bruno Engler Faleiros, Rafaela Vaz Pereira, Sylvia Stella Amaral, Thais Reis Lage, Gustavo Henrique Souza Resende, Patricia Alves Maia Guidine, Giselle Foureaux, Fabíola Mara Ribeiro, Fabiana Paiva Martins, Marco Antônio Peliky Fontes, Anderson José Ferreira, Remo Castro Russo, Mauro Martins Teixeira, Márcio Flávio Moraes, Antonio Lúcio Teixeira, Gustavo Batista Menezes 
World J Hepatol 6(4):243-250. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.243
Clinical Practice
Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome 
Mircea Dragoteanu, Ioan-Adrian Balea, Cecilia-Diana Piglesan 
World J Hepatol 6(4):251-262. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.251